Macrophage-targeted nanomedicine for chronic diseases immunotherapy

Volume: 33, Issue: 2, Pages: 597 - 612
Published: Feb 1, 2022
Abstract
Macrophage is the key innate immune effector in first-line defense against the pathogens, and can be polarized into different phenotypes to regulate a variety of immunological functions. However, the plasticity of macrophage is extraordinarily recruited, activated, and polarized under pathological conditions, playing paramount roles in occurrence, development, and prognosis of various chronic diseases, such as rheumatoid arthritis (RA),...
Paper Details
Title
Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Published Date
Feb 1, 2022
Volume
33
Issue
2
Pages
597 - 612
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.